Log in
Enquire now
‌

US Patent 10406142 Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom

Patent 10406142 was granted and assigned to 3M on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
3M
3M
0
Current Assignee
3M
3M
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
104061420
Patent Inventor Names
Paul D. Wightman0
Date of Patent
September 10, 2019
0
Patent Application Number
154508120
Date Filed
March 6, 2017
0
Patent Citations Received
‌
US Patent 11376323 Mixtures of polysaccharide protein pegylated compounds
‌
US Patent 11020486 Sesame oil based injection formulations
Patent Primary Examiner
‌
Kaipeen E Yang
0
Patent abstract

1H-Imidazo[4,5-c]quinolin-4-amines substituted at the 1-position with a substituent bearing a hydrazinobenzamide or hydrazinonicotinamide, a salt thereof, or a protected hydrazinobenzamide or hydrazinonicotinamide and conjugates made from such compounds are disclosed. Pharmaceutical compositions containing the compound or the conjugate, methods of making a conjugate, and methods of use of the compounds or conjugates as immunomodulators for inducing cytokine biosynthesis in an animal and for vaccinating an animal are also disclosed.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10406142 Hydrazino 1H-imidazoquinolin-4-amines and conjugates made therefrom

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.